3 Breakthrough Stocks Under $10 Set for Massive Upside

Core Insights - The article highlights three breakthrough stocks under $10, each demonstrating strong fundamentals and high upside potential in their respective sectors. Group 1: Arq (ARQ) - Arq produces activated carbon and environmentally efficient carbon products, reporting Q1 2024 revenue of $21.7 million, a 4% increase year-over-year despite a 6% reduction in volumes due to higher average selling prices and a favorable product mix [3][4] - The company's gross margin improved significantly to 37% from 17% in the previous year, indicating a focus on profitability over volume and effective operational cost management [3][4] - Arq secured a strategic supply contract for its GAC product, forecasting 5 million pounds per year, which represents approximately 20% of its Red River facility's capacity, with deliveries expected to start in Q1 2025 [4] Group 2: Amarin (AMRN) - Amarin specializes in cardiovascular disease treatments, achieving a 65% increase in in-market sales in Europe in Q1 2024 compared to Q4 2023, with significant contributions from Spain and the UK [5][6] - In Spain, the number of patients on VAZKEPA therapy increased by 91%, while the UK saw a 28% growth in patient numbers during the same period, indicating strong market acceptance and demand [5][6] - European net product revenue grew by 35% from Q4 2023, reflecting successful market access and reimbursement efforts, positioning Amarin as a top pick among breakthrough stocks under $10 [6] Group 3: OppFi (OPFI) - OppFi is a financial tech company that has improved its credit performance, with the net charge-off rate decreasing by 1.1 percentage points to 47.9% of total revenue in Q1 2024, indicating better credit quality [7][8] - Recoveries of previously charged-off loan balances increased by 33.5% annually, showcasing OppFi's enhanced ability to recover funds and contributing to its financial health [7] - The company's total expenses as a percentage of consolidated top-line increased by 1.1% annually to 45.5%, but adjusted expenses dropped by 2.7% to 40.6%, highlighting a focus on operational efficiency and cost control [8]